MCE
Trastuzumab deruxtecan
Trastuzumab deruxtecan
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
Couldn't load pickup availability
General Specifications
1) Purity: ≥99.0%2) Molecular Weight: 153000 (average)
3) Formula: N/A
4) CAS No.: 1826843-81-5
5) Appearance: Solid
6) Color: White to off-white
7) SMILE: [Trastuzumab deruxtecan]
8) Shipping: Shipping with dry ice.
9) Storage: -80°C, protect from light
Safety & Documentation
Error in entry: 1) Datasheet, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Datasheet_HY-138298A.pdf?v=1734506157 , 2) MSDS, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/MSDS_HY-138298A.pdf?v=1734506830 , 3) Handling Instruction, https://cdn.shopify.com/s/files/1/0716/2553/9802/files/Handling_Instructions_HY-138298A.pdf?v=1734506812
{# This line will help debug any improperly formatted entries #}
Disclaimer: Products are chemical reagents for research use
only and are not intended for human use. We do not sell to patients.